Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Mario, Barugel"'
Autor:
Ubaldo Alfredo Gualdrini, Alicia Sambuelli, Mario Barugel, Alejandro Gutiérrez, Karina Collia Ávila
Publikováno v:
Acta Gastroenterológica Latinoamericana, Vol 35, Iss 2, Pp 104-140 (2005)
El cáncer colorrectal (CCR) ocupa el segundo lugar en mortalidad por tumores malignos en Argentina. El riesgo de padecer un CCR a través de toda la vida es de 4-6%. A pesar de los avances en el tratamiento, la sobrevida a 5 años del CCR se ubica e
Externí odkaz:
https://doaj.org/article/534afa6085fb4c5089852b4ce59798d6
Autor:
Hui Jer Hwang, Claudia Bestani, René Jiménez, Guillermo Masciángioli, Alejandro Gutiérrez, Cristina Cartelli, Luisa Rafailovici, Mario Barugel, Gabriela Rodríguez, Guillermo Méndez
Publikováno v:
Acta Gastroenterológica Latinoamericana, Vol 35, Iss 2, Pp 94-98 (2005)
El carcinoma epidermoide del canal anal (CCA) constituye el 1.5% de los cánceres del sistema digestivo. La mayoría de los pacientes puede acceder a la cura a través de radioquimioterapia (RT-QT) concurrente. Objetivos: evaluar qué ocurrió con to
Externí odkaz:
https://doaj.org/article/8c267f98c66a4312acadf53f6b4eb4fd
Autor:
Hal Westhead, Mario Barugel, Piotr Wójcik, Pavel Fabian, Nikolaos Gouvas, J. Han van Krieken, Zuzana Traugottová, Samuel S. Murray, George Kafatos, Edit Molnar, Hana Vošmiková, Daniela Niepel, Sophie Jenkins-Anderson, Erika Toth, Antonios Bilalis, Tamer Garawin, Kimberley Lowe, George Papaxoinis, Nadia Mokhtar, Andrzej Tysarowski, Jörg Trojan, A. Skálová, József Tímár
Publikováno v:
Biomarkers in Medicine
Aim: A confirmed wild-type RAS tumor status is commonly required for prescribing anti-EGFR treatment for metastatic colorectal cancer. This noninterventional, observational research project estimated RAS mutation prevalence from real-world sources. M
Autor:
Ernesto Wasserman, Silvia Carraro, Luisa Rafailovici, Cristina Cartelli, Eduardo Huertas, Guillermo Masciangioli, Mario Barugel, Enrique Roca, Socorro Castillo Odena, Ubaldo Gualdrini, Maria Angeles Cabeza Rodriguez, Graciela Ballarino
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 54:397-402
Purpose: Oxaliplatin (OXA)/5-fluorouracil (5-FU) have confirmed their preclinical synergy in advanced colorectal cancer patients. Chemoradiotherapy with 5-FU + leucovorin (LV) is considered the standard treatment in unresectable rectal cancer patient
Autor:
Marina Antelo, Mario Barugel
Publikováno v:
Gastroenterología y Hepatología Continuada. 8:329-331
Autor:
Ubaldo Alfredo, Gualdrini, Alicia, Sambuelli, Mario, Barugel, Alejandro, Gutiérrez, Karina Collia, Avila
Publikováno v:
Acta gastroenterologica Latinoamericana. 35(2)
Colorectal cancer (CRC) is the second leading cause of cancer death in Argentina. The cumulative lifetime risk of developing CRC for both men and women is 4-6%. Despite advances in the management of this disease, the 5-year survival rate is about 60%
Autor:
Hui Jer, Hwang, Claudia, Bestani, René, Jiménez, Guillermo, Masciángioli, Alejandro, Gutiérrez, Cristina, Cartelli, Luisa, Rafailovici, Mario, Barugel, Gabriela, Rodríguez, Guillermo, Méndez
Publikováno v:
Acta gastroenterologica Latinoamericana. 35(2)
Anal cancers compromise only 1.5% of all digestive tumors. At present, concurrent radiochemotherapy (RT-CT) is the treatment of choice for most of these lesions.To collect and analyze clinical data from the medical records of all consecutive patients
Autor:
Masanobu Takahashi, Keun Hur, C. Richard Boland, Ana Cabanne, Millie A. Arnold, Yan Shen, María Dolores Giráldez, Francesc Balaguer, Ajay Goel, Luis Bujanda, Montserrat Andreu, Xavier Llor, Enrique Roca, Antoni Castells, Mario Barugel, Rodrigo Jover, Marina Antelo
Publikováno v:
Gastroenterology. 140:S-820
Autor:
Soledad, Iseas, Marcela, Carballido, Mariana, Coraglio, Fabio, Leiro, Adriana, Dieguez, Martin, Eleta, Guillermo, Mendez, Ariel, Aguilo, Mario, Barugel, Enrique, Roca
Publikováno v:
In Annals of Oncology June 2014 25 Supplement 2:ii99-ii99
Autor:
Antoni Castells, Enrique Roca, Keun Hur, Mildred Arnold, María Dolores Giráldez, Jinru Shia, Ajay Goel, Yan Shen, C. Richard Boland, Mario Barugel, Ana Cabanne, Rodrigo Jover, Miriam Cuatrecasas, Masanobu Takahashi, Montserrat Andreu, Francesc Balaguer, Luis Bujanda, Xavier Llor, Marina Antelo, Sergi Castellví-Bel, Leticia Moreira
Publikováno v:
Recercat. Dipósit de la Recerca de Catalunya
instname
Addi. Archivo Digital para la Docencia y la Investigación
PLoS ONE, Vol 7, Iss 9, p e45357 (2012)
Dipòsit Digital de la UB
Universidad de Barcelona
PLoS ONE
instname
Addi. Archivo Digital para la Docencia y la Investigación
PLoS ONE, Vol 7, Iss 9, p e45357 (2012)
Dipòsit Digital de la UB
Universidad de Barcelona
PLoS ONE
12 p. Objective: Early-onset colorectal cancer (CRC) represents a clinically distinct form of CRC that is often associated with a poor prognosis. Methylation levels of genomic repeats such as LINE-1 elements have been recognized as independent factor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43c0efaaa28a22cc71ac6896fa39a8a8
http://hdl.handle.net/2445/124828
http://hdl.handle.net/2445/124828